Company Profiles

driven by the PitchBook Platform

Antoxis

Description

Provider of a drug discovery platform intended to serve in regenerative medice applications and mitocondrial related diseases. The company's drug discovery platform utilizes its patented Kromex™ chemistry scaffold to generate New Chemical Entities (NCE) that protects over 100 Million compounds, enabling physicians to treat neurodegenerative diseases and cancer.

2005

Founded

PRIVATE

Status

Later Stage VC

Latest Deal Type

$934k

Total Amount Raised

6

Investors

Description

Provider of a drug discovery platform intended to serve in regenerative medice applications and mitocondrial related diseases. The company's drug discovery platform utilizes its patented Kromex™ chemistry scaffold to generate New Chemical Entities (NCE) that protects over 100 Million compounds, enabling physicians to treat neurodegenerative diseases and cancer.

Website:

www.antoxis.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

IMS Building Foresterhill Health and Research Complex Aberdeen AB25 2ZDScotland +44 (0)12 2443 8571
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Antoxis's full profile, request a free trial.

    Antoxis Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Antoxis Investors (6)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Genomia FundVenture CapitalMinority000 0000000 0000
    Grampian BiopartnersVenture CapitalMinority000 0000000 0000
    Kapital VenturesVenture CapitalMinority000 0000000 0000
    Scottish EnterpriseVenture CapitalMinority000 0000000 0000
    TRI CapAngel GroupMinority000 0000000 0000
    Genomia Fund Venture Capital
    Grampian Biopartners Venture Capital
    Kapital Ventures Venture Capital
    Scottish Enterprise Venture Capital
    TRI Cap Angel Group

    Antoxis Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Donald McPhailCo-Founder, Chief Scientific Officer & Scientific Consultant
    Leslie Patmore Ph.DDirector of Drug Development
    Keith WintonBoard Observer and Company Secretary
    Andrew JohnstoneFounder, Board Member & Chief Executive Officer
    Donald McPhail Co-Founder, Chief Scientific Officer & Scientific Consultant
    Leslie Patmore Ph.D Director of Drug Development
    Keith Winton Board Observer and Company Secretary
    Andrew Johnstone Founder, Board Member & Chief Executive Officer

    Antoxis Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Andrew JohnstoneSelfFounder, Board Member & Chief Executive Officer000 0000
    Andrew Porter Ph.DGrampian BiopartnersCo-Founder000 0000
    Douglas ThomsonSelfBoard Member000 0000
    Keith WintonAntoxisBoard Observer and Company Secretary000 0000
    Malcolm GilliesSelfBoard Member000 0000
    Andrew Johnstone Founder, Board Member & Chief Executive Officer Self
    Andrew Porter Ph.D Co-Founder Grampian Biopartners
    Douglas Thomson Board Member Self
    Keith Winton Board Observer and Company Secretary Antoxis
    Malcolm Gillies Board Member Self
    Request full access to PitchBook